APA (7th ed.) Citation

J, M., A, C., M, A., L, D., J, D., SG, T., . . . DE, S. (2023). CRISPR/Cas9 Screen in Gastric Cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability. Small methods, 7(6), e2201605. https://doi.org/10.1002/smtd.202201605

Chicago Style (17th ed.) Citation

J, Mircetic, et al. "CRISPR/Cas9 Screen in Gastric Cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability." Small Methods 7, no. 6 (2023): e2201605. https://doi.org/10.1002/smtd.202201605.

MLA (9th ed.) Citation

J, Mircetic, et al. "CRISPR/Cas9 Screen in Gastric Cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability." Small Methods, vol. 7, no. 6, 2023, p. e2201605, https://doi.org/10.1002/smtd.202201605.